Rosario Guarrasi

Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

Raffaele Addeo, Michele Caraglia, Sergio Bellini et al. · Journal of Clinical Oncology · 2009 · 190 citations

Medicine, Oncology, Pharmacology +13

Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases

Raffaele Addeo, Carmine De Rosa, Vincenzo Faiola et al. · Cancer · 2008 · 91 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study

Salvatore Del Prete, Liliana Montella, Michele Caraglia et al. · Cancer Chemotherapy and Pharmacology · 2009 · 79 citations · Full text

Medicine, Oncology, Pharmacology +14

Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life

Raffaele Addeo, Michele Caraglia, Vincenzo Faiola et al. · BMC Cancer · 2007 · 76 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients

Giampaolo Tortora, Fortunato Ciardiello, Stefano Pepe et al. · PubMed · 1995 · 71 citations

Medicine, Oncology, Pharmacology +17